Komori
Alfresa Holdings (2784) · FactFirst stated

Total capital expenditures for FY2025: ¥16.466 billion

First written in FY2025. . Latest entry: FY2025.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Annual Capital Investment in the Pharmaceutical Wholesale BusinessA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2025First statedAnnual report

    「当連結会計年度の設備投資の内訳は、医療用医薬品等卸売事業12,432百万円、セルフメディケーション卸売事業733百万円、医薬品等製造事業1,930百万円、医療関連事業562百万円、計15,659百万円、消去または全社807百万円、合計16,466百万円であります。」

    FY2025の設備投資は合計164億66百万円で、医療用医薬品等卸売事業を中心に実施した。
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Alfresa Holdings yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.